An Alzheimer’s treatment from idea to market can take up to 20 years. After a long hiatus, the U.S. Food and Drug Administration (FDA) has approved three new drugs to treat Alzheimer’s since June 2021 ...
New research indicates that brainstem damage may be the cause of ongoing symptoms in severe Covid-19 survivors, affecting functions like breathing and anxiety.